Fluvoxamine maleate - CAS 61718-82-9
Catalog number: B0084-073281
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C19H25F3N2O6
Molecular Weight:
434.412
COA:
Inquire
Targets:
SSRIs
Description:
Fluvoxamine maleate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) and sigma-1 receptor agonist.
Ordering Information
Catalog Number Size Price Stock Quantity
B0084-073281 5 g $238 In stock
Bulk Inquiry
Purity:
>98%
Related CAS:
54739-18-3 (free base)
Appearance:
White Solid
Synonyms:
(E)-5-Methoxy-1-[4-(triflurormethyl)phenyl]-1-pentanone O-(2-Aminoethyl)oxime Maleate; DU-23000; MK-264; Dumirox; Faverin; Fevarin; Floxyfral; Luvox; Maveral
Storage:
Store at -20°C
MSDS:
Inquire
Melting Point:
120-125°C
InChIKey:
LFMYNZPAVPMEGP-PIDGMYBPSA-N
InChI:
InChI=1S/C15H21F3N2O2.C4H4O4/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18;5-3(6)1-2-4(7)8/h5-8H,2-4,9-11,19H2,1H3;1-2H,(H,5,6)(H,7,8)/b20-14+;2-1-
Canonical SMILES:
COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O
1.The effects of fluvoxamine on the steady-state plasma concentrations of escitalopram and desmethylescitalopram in depressed Japanese patients.
Yasui-Furukori N1, Tsuchimine S, Kubo K, Ishioka M, Nakamura K, Inoue Y. Ther Drug Monit. 2016 Mar 21. [Epub ahead of print]
BACKGROUND: The aim of this study was to determine the impact of fluvoxamine, an inhibitor of CYP2C19, on the pharmacokinetics of escitalopram, a substrate of CYP2C19.
2.A Review of Pharmacologic Treatment for Compulsive Buying Disorder.
Soares C1, Fernandes N2, Morgado P2,3,4. CNS Drugs. 2016 Apr 11. [Epub ahead of print]
At present, no treatment recommendations can be made for compulsive buying disorder. Recent studies have found evidence for the efficacy of psychotherapeutic options, but less is known regarding the best pharmacologic treatment. The purpose of this review is to present and analyze the available published evidence on the pharmacological treatment of compulsive buying disorder. To achieve this, we conducted a review of studies focusing on the pharmacological treatment of compulsive buying by searching the PubMed/MEDLINE database. Selection criteria were applied, and 21 studies were identified. Pharmacological classes reported included antidepressants, mood stabilizers, opioid antagonists, second-generation antipsychotics, and N-methyl-D-aspartate receptor antagonists. We found only placebo-controlled trials for fluvoxamine; none showed effectiveness against placebo. Three open-label trials reported clinical improvement with citalopram; one was followed by a double-blind discontinuation.
3.Yokukansan improves behavioral and psychological symptoms of dementia by suppressing dopaminergic function.
Takeyoshi K1, Kurita M2, Nishino S3, Teranishi M4, Numata Y5, Sato T5, Okubo Y4. Neuropsychiatr Dis Treat. 2016 Mar 15;12:641-9. doi: 10.2147/NDT.S99032. eCollection 2016.
Although three drugs, risperidone, yokukansan, and fluvoxamine, have shown equal efficacy in treating behavioral and psychological symptoms of dementia (BPSD) in our previous study, their mechanisms of action are different from one another. Monoamines have attracted attention for their key roles in mediating several behavioral symptoms or psychological symptoms through synaptic signaling. We aimed to clarify the monoamines changed by treatment with each drug in patients with BPSD. The main purpose of this study was to determine whether plasma levels of catecholamine metabolites are correlated with pharmacological treatments. This was an 8-week, rater-blinded, randomized, flexible-dose, triple-group trial. In total, 90 subjects were recruited and subsequently three different drugs were allocated to 82 inpatients with BPSD. We examined BPSD data from patients who completed 8 weeks of treatment. Eventually, we analyzed 42 patients (yokukansan: 17; risperidone: 9; fluvoxamine: 16).
4.Serotonin syndrome presenting as pulmonary edema.
Shah ND1, Jain AB2. Indian J Pharmacol. 2016 Jan-Feb;48(1):93-5. doi: 10.4103/0253-7613.174575.
Serotonin syndrome (SS) is a potentially life-threatening condition resulting from excessive central and peripheral serotonergic activity. Clinically, it is a triad of mental-status changes, neuromuscular abnormalities, and autonomic disturbances. It can be caused by intentional self-poisoning, overdose, or inadvertent drug interactions. We report the case of a 58-year-old male with type 2 diabetes mellitus and obsessive compulsive disorder who developed pulmonary edema as a possible complication of SS. SS was caused by a combination of three specific serotonin re-uptake inhibitors (fluoxetine, fluvoxamine, and sertraline), linezolid, and fentanyl. The hospital course was further complicated by difficult weaning from the ventilator. SS was identified and successfully treated with cyproheptadine and lorazepam. The case highlights the importance of effective consultation-liaison and prompt recognition of SS as the presentation may be complex in the presence of co-morbid medical illness.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related SSRIs Products


CAS 110429-35-1 Paroxetine hydrochloride hemihydrate

Paroxetine hydrochloride hemihydrate
(CAS: 110429-35-1)

Paroxetine hydrochloride hemihydrate is a antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs).

CAS 92623-85-3 Milnacipran

Milnacipran
(CAS: 92623-85-3)

Milnacipran is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia. It is not approved for the clinical treatmen...

CAS 54910-89-3 Fluoxetine

Fluoxetine
(CAS: 54910-89-3)

class. It delays the reuptake of serotonin, resulting in serotonin persisting longer when it is released. It may also produce some of its effects via its weak 5...

CAS 79559-97-0 Sertraline HCl

Sertraline HCl
(CAS: 79559-97-0)

Sertraline HCl is a 5-HT antagonist with Ki of 13 nM.

CAS 136434-34-9 Duloxetine Hydrochloride

Duloxetine Hydrochloride
(CAS: 136434-34-9)

Duloxetine Hydrochloride is a serotonin-norepinephrine reuptake inhibitor with Ki of 4.6 nM, used for treatment of major depressive disorder and generalized anx...

CAS 54739-18-3 Fluvoxamine

Fluvoxamine
(CAS: 54739-18-3)

Fluvoxamine is an antidepressant which functions pharmacologically as a selective serotonin reuptake inhibitor. It is effective in inhibiting 5-ht uptake by blo...

CAS 61718-82-9 Fluvoxamine maleate

Fluvoxamine maleate
(CAS: 61718-82-9)

Fluvoxamine maleate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) and sigma-1 receptor agonist.

CAS 93413-69-5 Venlafaxine

Venlafaxine
(CAS: 93413-69-5)

Venlafaxine is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class, but it has been referred to as a serotonin-norepinephrine-dopa...

CAS 19794-93-5 Trazodone

Trazodone
(CAS: 19794-93-5)

Trazodone, a phenylpiperazine compound, acts as a serotonin uptake inhibitor with antianxiety (anxiolytic) and sleep-inducing (hypnotic) effects.

CAS 129938-20-1 Dapoxetine hydrochloride

Dapoxetine hydrochloride
(CAS: 129938-20-1)

Dapoxetine HCl is a short-acting novel selective serotonin reuptake inhibitor.

CAS 219861-08-2 Escitalopram Oxalate

Escitalopram Oxalate
(CAS: 219861-08-2)

Escitalopram Oxalate also known by the brand names Lexapro and Cipralex among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) ...

CAS 386750-22-7 Desvenlafaxine Succinate

Desvenlafaxine Succinate
(CAS: 386750-22-7)

Desvenlafaxine Succinate is a new serotonin (5-HT) transporter and norepinephrine (NE) transporter reuptake inhibitor with Ki of 40.2 nM and 558.4 nM respective...

CAS 56296-78-7 Fluoxetine hydrochloride

Fluoxetine hydrochloride
(CAS: 56296-78-7)

Fluoxetine is a selective serotonin-reuptake inhibitor (SSRI) at the neuronal membrane, used in the treatment of depression.

CAS 1229-29-4 Doxepin Hydrochloride

Doxepin Hydrochloride
(CAS: 1229-29-4)

Highly potent H1 histamine receptor antagonist (Kd = 310 pM) and tricyclic antidepressant. Also binds to the H4 histamine receptor (pKi = 6.79).

CAS 128196-01-0 Escitalopram

Escitalopram
(CAS: 128196-01-0)

Escitalopram, the S-enantiomer of citalopram, belongs to a class of antidepressant agents known as selective serotonin-reuptake inhibitors (SSRIs). Escitalopram...

CAS 175131-60-9 Levomilnacipran Hydrochloride

Levomilnacipran Hydrochloride
(CAS: 175131-60-9)

Levomilnacipran (brand name Fetzima) is an antidepressant approved for the treatment of major depressive disorder in the United States. It was developed by Fore...

CAS 24853-80-3 Azaphen

Azaphen
(CAS: 24853-80-3)

An antidepressant having effects on the autonomic nervous system; the drug is especially effective for mild and moderate depressions and a combination of Azaphe...

CAS 63302-99-8 Azaphen dihydrochloride monohydrate

Azaphen dihydrochloride monohydrate
(CAS: 63302-99-8)

Azaphen dihydrochloride monohydrate is a potent inhibitor of the reuptake of serotonin. It is a tricyclic antidepressant (TCA) approved in Russia for the treatm...

CAS 93413-62-8 Desvenlafaxine

Desvenlafaxine
(CAS: 93413-62-8)

Desvenlafaxine is a serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor with Ki of 40.2 nM and 558.4 nM, respectively.

CAS 99300-78-4 Venlafaxine hydrochloride

Venlafaxine hydrochloride
(CAS: 99300-78-4)

Venlafaxine hydrochloride is an antidepressant of the serotonin-norepinephrine reuptake inhibitor (SNRI) class, but it has been referred to as a serotonin-norep...

Chemical Structure

CAS 61718-82-9 Fluvoxamine maleate

Quick Inquiry

Verification code

Featured Items